Brain Imaging of Cognition Inn Schizophrenia and Depression

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Schizophrenia and depression are among the most disabling disorders in all of medicine. Cognitive deficits play a key role in patients' disability, affecting their capacity to contribute actively to society by sustaining employment or academic activity. Moreover, cognitive difficulties tend to persist even after the stabilization of other clinical symptoms. Verbal memory and emotion regulation are two important cognitive domains that are impaired in schizophrenia and depression and are associated with patients' functional outcomes. In this study, we are using brain imaging to investigate the brain mechanisms underlying these cognitive deficits in these populations.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• age 18-65 years

• current Intelligence Quotient (IQ) \> 70 as measured by the Wechsler Abbreviated Scale of Intelligence (WASI)

• the ability to read and speak fluent English

• a diagnosis of schizophrenia, schizoaffective or major depression disorder

• stable medication for more than one month

Locations
Other Locations
Canada
Royal Ottawa Mental Health Center
RECRUITING
Ottawa
Contact Information
Primary
Synthia Guimond, PhD
Synthia.Guimond@theroyal.ca
6137226521
Time Frame
Start Date: 2019-12-12
Estimated Completion Date: 2026-10-01
Participants
Target number of participants: 90
Treatments
Individuals with Schizophrenia or Schzioaffective Disorders
Clinical group
Individuals with Major Depressive Disorder
Clinical group
Healthy Individuals
Control group
Related Therapeutic Areas
Sponsors
Leads: The Royal Ottawa Mental Health Centre

This content was sourced from clinicaltrials.gov